Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age
NCT01897753 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 264
Last updated 2014-01-20
Summary
The purpose of this protocol is to retrospectively study the influence of age at start of growth hormone (GH) treatment on height gain in children born small for gestational age (SGA).
Conditions
- Small For Gestational Age (SGA)
Interventions
- DRUG
-
growth hormone
36 months
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 4 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2013-09-30
- Completion
- 2013-09-30
Countries
- Spain
Study Locations
More Related Trials
-
Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy
NCT00625872 ·Status: TERMINATED ·Phase: PHASE3
-
Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction
NCT00519844 ·Status: COMPLETED ·Phase: PHASE4
-
Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age
NCT00174460 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height
NCT00396474 ·Status: WITHDRAWN
-
Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation
NCT01734447 ·Status: COMPLETED ·Phase: PHASE4
-
Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)
NCT00184717 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT05894876 ·Status: TERMINATED
-
Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese"
NCT01897766 ·Status: COMPLETED
-
Growth Hormone Treatment in Short Children Born Small for Gestational Age
NCT00191529 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Long-term Somatropin Treatment in Children
NCT01543867 ·Status: COMPLETED
-
Genotropin Treatment In Very Young Children Born Small For Gestational Age
NCT00627523 ·Status: COMPLETED ·Phase: PHASE3
-
Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
NCT01073605 ·Status: COMPLETED ·Phase: PHASE3
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
French National Registry of Children Born Small for Gestational Age Treated With Somatropin
NCT01578135 ·Status: COMPLETED
-
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
NCT00174408 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
NCT03972345 ·Status: ENROLLING_BY_INVITATION
-
Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature
NCT02375620 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation
NCT01697644 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
NCT01604395 ·Status: RECRUITING
-
Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing
NCT01110928 ·Status: COMPLETED
-
Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH)
NCT00597480 ·Status: TERMINATED ·Phase: PHASE4
-
Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age
NCT01491854 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of DA-3002 in Short Children Borns SGA.
NCT02770157 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Children With Insufficient Secretion of Growth Hormone
NCT00271518 ·Status: UNKNOWN ·Phase: PHASE3
-
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
NCT00488124 ·Status: COMPLETED ·Phase: PHASE2